🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine

RecruitingNAAges 18 Years - 65 YearsAllCairo University
NCT06974617 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This trial compares the efficacy and safety of sphenopalatine ganglion block (SPGB) and intramuscular BOTOX injection in chronic migraine.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 and 65 years. * Both sexes. * Chronic migraine. Chronic migraine, defined as headaches on ≥15 days per month for ≥3 months, of which ≥8 days meet criteria for migraine without aura or respond to migraine-specific treatment according to International Classification of Headache Disorders-3 Beta. Exclusion Criteria: * Patients with medication over use headache. * Bleeding disorders. * Abnormal neurological examination. * History of allergy to local anesthetics or BOTOX.
💊

What it tests

  • Sphenopalatine block
  • Botulinum Toxin Type A
📍

Where

1 site
Cairo University
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy